LOW-DOSE IL-2 RESTORES TREG-MEDIATED IMMUNE TOLERANCE IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS

被引：1
|
作者：
Wu, R. [1 ]
Su, R. [1 ]
Ding, T. [1 ]
Xue, H. [1 ]
An, J. [1 ]
Jiang, L. [1 ]
Li, X. F. [1 ]
Wang, C. [1 ]
机构：
[1] Shanxi Med Univ, Hosp 2, Taiyuan, Peoples R China
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.4346
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0278
引用
收藏
页码：1079 / 1080
页数：2
相关论文
共 50 条
  • [41] Endogenous IL-33 contributes to Treg expansion induced by IL-2/CD25, a novel IL-2 biologic developed for low-dose IL-2 therapy
    Lui, Jen Bon P.
    Malek, Thomas R.
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [42] EFFICACY OF ULTRA-LOW DOSE RITUXIMAB FOR REMISSION MAINTENANCE THERAPY IN ANCA-ASSOCIATED VASCULITIS
    Campaniello, D.
    Treppo, E.
    D'onofrio, B.
    Franchi, G.
    Berti, A.
    Iorio, L.
    Bortolotti, R.
    Montecucco, C.
    Monti, S.
    Quartuccio, L.
    Doria, A.
    Schiavon, F.
    Padoan., R.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 710 - 710
  • [43] Low-dose IL-2 mitigates glucocorticoid-induced Treg impairment and promotes improvement of SLE
    Haotian Zhou
    Xiaozhen Zhao
    Ruijun Zhang
    Miao Miao
    Wenwen Pei
    Zijun Li
    Yimin Li
    Jing He
    Zhanguo Li
    Xiaolin Sun
    Signal Transduction and Targeted Therapy, 8
  • [44] Low-dose IL-2 mitigates glucocorticoid-induced Treg impairment and promotes improvement of SLE
    Zhou, Haotian
    Zhao, Xiaozhen
    Zhang, Ruijun
    Miao, Miao
    Pei, Wenwen
    Li, Zijun
    Li, Yimin
    He, Jing
    Li, Zhanguo
    Sun, Xiaolin
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [45] Low-dose IL-2 therapy for autoimmune diseases
    Collison J.
    Nature Reviews Rheumatology, 2019, 15 (1) : 2 - 2
  • [46] Tolerance of mycophenolate mofetil in end-stage renal disease patients with ANCA-associated vasculitis
    Haubitz, M
    de Groot, K
    CLINICAL NEPHROLOGY, 2002, 57 (06) : 421 - 424
  • [47] Therapeutic potential of low-dose IL-2 in immune thrombocytopenia: An analysis of 3 cases
    Zhang, Jiakui
    Ruan, Yanjie
    Xu, Xuanxuan
    Wang, Huiping
    Tao, Qianshan
    Lu, Jun
    Xia, Linhuan
    Zhang, Qiuye
    Wang, Jeffrey
    Wang, Yiping
    Zhai, Zhimin
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2018, 94 (03) : 428 - 433
  • [48] LOW-DOSE IL-2 INDUCES REGULATORY T CELL RECOVERY AND CLINICAL IMPROVEMENT IN HCV-ASSOCIATED CRYOGLOBULINEMIC VASCULITIS
    Saadoun, David
    Rosenzwajg, M.
    Joly, Florence
    Carrat, Fabrice
    Sene, D.
    Klatzmann, David
    Cacoub, Patrice
    HEPATOLOGY, 2011, 54 : 966A - 966A
  • [49] The absolute number of circulating Treg cells is reduced in difficult-to-treat RA patients and is ameliorated by low-dose IL-2
    Yan, Huanhuan
    Zi, Xiaoyu
    Yan, Huer
    Zhang, Xiaoying
    Bai, Jie
    Gao, Chong
    Li, Xiaofeng
    Wang, Caihong
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [50] THE UTILITY OF LOW DOSE RITUXIMAB FOR INDUCTION AND MAINTENANCE TREATMENT IN ELDERLY PATIENTS WITH ANCA-ASSOCIATED VASCULITIS: A SINGLE CENTRE EXPERIENCE
    Metraiah, El Hakem
    Dospinescu, Paula
    Fluck, Nicholas
    Basu, Neil
    Kidder, Dana
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 688 - 688
12345